Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Rheumatoid Arthritis

Free Subscription Articles published in Clin Rheumatol Retrieve available abstracts of 300 articles: HTML format Text format

Single Articles

June 2018
1. AL-GAREEB AIA, Gorial FI, Mahmood AS
   Niclosamide as an adjuvant to etanercept in treatment patients with active rheumatoid arthritis: an 8-week randomized controlled pilot study.
   Clin Rheumatol. 2018 Jun 7. pii: 10.1007/s10067-018-4164.
   PubMed     Text format     Abstract available
   
   
   
2. SHIMADA K, Yokosuka K, Nunokawa T, Sugii S, et al
   Differences in clinical Pneumocystis pneumonia in rheumatoid arthritis and other connective tissue diseases suggesting a rheumatoid-specific interstitial lung injury spectrum.
   Clin Rheumatol. 2018 Jun 6. pii: 10.1007/s10067-018-4157.
   PubMed     Text format     Abstract available
   
   
   
3. KAVANAUGH A, Singh R, Karki C, Etzel CJ, et al
   Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis.
   Clin Rheumatol. 2018 Jun 4. pii: 10.1007/s10067-018-4140.
   PubMed     Text format     Abstract available
   
   
   May 2018
4. ZHU T, Zhao WL, Zeng YP, Liu YH, et al
   Systemic sclerosis-rheumatoid arthritis overlap syndrome complicated with Sweet's syndrome.
   Clin Rheumatol. 2018 May 25. pii: 10.1007/s10067-018-4150.
   PubMed     Text format     Abstract available
   
   
   
5. BAE SC, Lee YH
   Vitamin D level and risk of systemic lupus erythematosus and rheumatoid arthritis: a Mendelian randomization.
   Clin Rheumatol. 2018 May 24. pii: 10.1007/s10067-018-4152.
   PubMed     Text format     Abstract available
   
   
   
6. RAMBOD M, Nazarinia M, Raieskarimian F
   The impact of dietary habits on the pathogenesis of rheumatoid arthritis: a case-control study.
   Clin Rheumatol. 2018 May 22. pii: 10.1007/s10067-018-4151.
   PubMed     Text format     Abstract available
   
   
   
7. TURK SM, Cansu DU, Teke HU, Kasifoglu T, et al
   Can we predict thrombotic tendency in rheumatoid arthritis? A thromboelastographic analysis (with ROTEM).
   Clin Rheumatol. 2018 May 7. pii: 10.1007/s10067-018-4134.
   PubMed     Text format     Abstract available
   
   
   April 2018
8. PAPPAS DA, Nyberg F, Kremer JM, Lampl K, et al
   Prevalence of cardiovascular disease and major risk factors in patients with rheumatoid arthritis: a multinational cross-sectional study.
   Clin Rheumatol. 2018 Apr 25. pii: 10.1007/s10067-018-4113.
   PubMed     Text format     Abstract available
   
   
   
9. QUINTANA R, Goni M, Mathern N, Jorfen M, et al
   Rheumatoid arthritis in the indigenous qom population of Rosario, Argentina: aggressive and disabling disease with inadequate adherence to treatment in a community-based cohort study.
   Clin Rheumatol. 2018 Apr 19. pii: 10.1007/s10067-018-4103.
   PubMed     Text format     Abstract available
   
   
   
10. LUO Y, Fan X, Jiang C, Arevalo Molina AB, et al
    Rheumatoid arthritis is associated with increased in-hospital mortality in asthma exacerbations: a nationwide study.
    Clin Rheumatol. 2018 Apr 19. pii: 10.1007/s10067-018-4114.
    PubMed     Text format     Abstract available
    
    
    
11. TYMMS K, Littlejohn G, Griffiths H, de Jager J, et al
    Treatment patterns among patients with rheumatic disease (rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA) and undifferentiated arthritis (UnA)) treated with subcutaneous TNF inhibitors.
    Clin Rheumatol. 2018 Apr 18. pii: 10.1007/s10067-018-4105.
    PubMed     Text format     Abstract available
    
    
    
12. GAO H, Ma XX, Guo Q, Xie LF, et al
    Expression of circulating Semaphorin3A and its association with inflammation and bone destruction in rheumatoid arthritis.
    Clin Rheumatol. 2018 Apr 14. pii: 10.1007/s10067-018-4070.
    PubMed     Text format     Abstract available
    
    
    
13. STRAND V, Lee EB, Yazici Y, Dikranian A, et al
    Evaluation of disease activity in patients with rheumatoid arthritis treated with tofacitinib by RAPID3: post hoc analyses from two phase 3 trials.
    Clin Rheumatol. 2018 Apr 14. pii: 10.1007/s10067-018-4077.
    PubMed     Text format     Abstract available
    
    
    
14. HURNAKOVA J, Hulejova H, Zavada J, Komarc M, et al
    Serum calprotectin may reflect inflammatory activity in patients with active rheumatoid arthritis despite normal to low C-reactive protein.
    Clin Rheumatol. 2018 Apr 14. pii: 10.1007/s10067-018-4091.
    PubMed     Text format     Abstract available
    
    
    
15. KOOHINI Z, Hossein-Nataj H, Mobini M, Hosseinian-Amiri A, et al
    Analysis of PD-1 and Tim-3 expression on CD4(+) T cells of patients with rheumatoid arthritis; negative association with DAS28.
    Clin Rheumatol. 2018 Apr 7. pii: 10.1007/s10067-018-4076.
    PubMed     Text format     Abstract available
    
    
    
16. KHOJAH HM, Ahmed S, Abdel-Rahman MS, Elhakeim EH, et al
    Resveratrol as an effective adjuvant therapy in the management of rheumatoid arthritis: a clinical study.
    Clin Rheumatol. 2018 Apr 3. pii: 10.1007/s10067-018-4080.
    PubMed     Text format     Abstract available
    
    
    March 2018
17. SUDA M, Ohde S, Tsuda T, Kishimoto M, et al
    Safety and efficacy of alternate-day corticosteroid treatment as adjunctive therapy for rheumatoid arthritis: a comparative study.
    Clin Rheumatol. 2018 Mar 26. pii: 10.1007/s10067-018-4073.
    PubMed     Text format     Abstract available
    
    
    
18. ANNO S, Sugioka Y, Inui K, Tada M, et al
    Evaluation of work disability in Japanese patients with rheumatoid arthritis: from the TOMORROW study.
    Clin Rheumatol. 2018 Mar 10. pii: 10.1007/s10067-018-4060.
    PubMed     Text format     Abstract available
    
    
    
19. FERREIRA RJO, Eugenio G, Ndosi M, Silva C, et al
    Influence of the different "patient global assessment" formulations on disease activity score by different indices in rheumatoid arthritis.
    Clin Rheumatol. 2018 Mar 10. pii: 10.1007/s10067-018-4063.
    PubMed     Text format     Abstract available
    
    
    
20. YANG L, Zou QH, Zhang Y, Shi Y, et al
    Proteomic analysis of plasma from rheumatoid arthritis patients with mild cognitive impairment.
    Clin Rheumatol. 2018 Mar 10. pii: 10.1007/s10067-017-3974.
    PubMed     Text format     Abstract available
    
    
    
21. ENGELMANN R, Nekarda S, Kuthning D, Kneitz C, et al
    Decreased IgG4 ACPA levels in responders and increased CD1c(+) classical dendritic cells in non-responders of patients with rheumatoid arthritis under therapy.
    Clin Rheumatol. 2018 Mar 3. pii: 10.1007/s10067-018-4053.
    PubMed     Text format     Abstract available
    
    
    
22. DES BORDES JKA, Gonzalez E, Lopez-Olivo MA, Shethia M, et al
    Assessing information needs and use of online resources for disease self-management in patients with rheumatoid arthritis: a qualitative study.
    Clin Rheumatol. 2018 Mar 2. pii: 10.1007/s10067-018-4047.
    PubMed     Text format     Abstract available
    
    
    February 2018
23. HUANG Z, Niu Q, Yang B, Zhang J, et al
    Genetic polymorphism of rs9277535 in HLA-DP associated with rheumatoid arthritis and anti-CCP production in a Chinese population.
    Clin Rheumatol. 2018 Feb 23. pii: 10.1007/s10067-018-4030.
    PubMed     Text format     Abstract available
    
    
    
24. GOSSEC L, Kirwan JR, de Wit M, Balanescu A, et al
    Phrasing of the patient global assessment in the rheumatoid arthritis ACR/EULAR remission criteria: an analysis of 967 patients from two databases of early and established rheumatoid arthritis patients.
    Clin Rheumatol. 2018 Feb 21. pii: 10.1007/s10067-018-3998.
    PubMed     Text format     Abstract available
    
    
    
25. PERROTTA FM, De Socio A, Scriffignano S, Lubrano E, et al
    Residual disease activity in rheumatoid arthritis patients treated with subcutaneous biologic drugs that achieved remission or low disease activity: a longitudinal observational study.
    Clin Rheumatol. 2018 Feb 21. pii: 10.1007/s10067-018-4038.
    PubMed     Text format     Abstract available
    
    
    
26. MEDINA YF, Ruiz-Gaviria RE, Buitrago-Lopez A, Villota C, et al
    Physical articular examination in the activity of rheumatoid arthritis: a systematic review of the literature : Systematic review of the literature regarding physical examination in rheumatoid arthritis.
    Clin Rheumatol. 2018 Feb 20. pii: 10.1007/s10067-018-4015.
    PubMed     Text format     Abstract available
    
    
    
27. LI J, Che N, Xu L, Zhang Q, et al
    LC-MS-based serum metabolomics reveals a distinctive signature in patients with rheumatoid arthritis.
    Clin Rheumatol. 2018 Feb 13. pii: 10.1007/s10067-018-4021.
    PubMed     Text format     Abstract available
    
    
    
28. SARI F, Oskay D, Tufan A
    Reliability, validity, and cross-cultural adaptation of the Turkish version of the Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional Questionnaire.
    Clin Rheumatol. 2018 Feb 8. pii: 10.1007/s10067-018-4008.
    PubMed     Text format     Abstract available
    
    
    
29. GUNTER S, Robinson C, Norton GR, Woodiwiss AJ, et al
    Disease severity impacts the relationship of apelin with arterial function in patients with rheumatoid arthritis.
    Clin Rheumatol. 2018 Feb 8. pii: 10.1007/s10067-018-4013.
    PubMed     Text format     Abstract available
    
    
    
30. BAE SC, Lee YH
    Comparison of the efficacy and tolerability of tocilizumab, sarilumab, and sirukumab in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials.
    Clin Rheumatol. 2018 Feb 5. pii: 10.1007/s10067-018-4006.
    PubMed     Text format     Abstract available
    
    
    
31. VERSTEEG GA, Steunebrink LMM, Vonkeman HE, Ten Klooster PM, et al
    Long-term disease and patient-reported outcomes of a continuous treat-to-target approach in patients with early rheumatoid arthritis in daily clinical practice.
    Clin Rheumatol. 2018 Feb 1. pii: 10.1007/s10067-017-3962.
    PubMed     Text format     Abstract available
    
    
    
32. BAE SC, Lee YH
    Comparative efficacy and safety of biosimilar adalimumab and originator adalimumab in combination with methotrexate in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials.
    Clin Rheumatol. 2018 Feb 1. pii: 10.1007/s10067-018-4002.
    PubMed     Text format     Abstract available
    
    
    January 2018
33. KARDOS Z, Olah C, Sepsi M, Sas A, et al
    Increased frequency of temporal acoustic window failure in rheumatoid arthritis: a manifestation of altered bone metabolism?
    Clin Rheumatol. 2018 Jan 30. pii: 10.1007/s10067-018-4003.
    PubMed     Text format     Abstract available
    
    
    
34. CONN DL, Tiliakos A, Bao G, Liu S, et al
    Correction to: Effect of daily low dose prednisone, divided or single daily dose, in the treatment of African Americans with early rheumatoid arthritis.
    Clin Rheumatol. 2018 Jan 29. pii: 10.1007/s10067-018-3996.
    PubMed     Text format     Abstract available
    
    
    
35. PETERSEN LE, Baptista TSA, Molina JK, Motta JG, et al
    Cognitive impairment in rheumatoid arthritis: role of lymphocyte subsets, cytokines and neurotrophic factors.
    Clin Rheumatol. 2018 Jan 25. pii: 10.1007/s10067-018-3990.
    PubMed     Text format     Abstract available
    
    
    
36. ROMANO C, Del Mastro A, Sellitto A, Solaro E, et al
    Tocilizumab reduces complement C3 and C4 serum levels in rheumatoid arthritis patients.
    Clin Rheumatol. 2018 Jan 23. pii: 10.1007/s10067-018-3992.
    PubMed     Text format     Abstract available
    
    
    
37. KIADALIRI AA, Englund M
    Temporal trends and regional disparity in rheumatoid arthritis and gout hospitalizations in Sweden, 1998-2015.
    Clin Rheumatol. 2018 Jan 22. pii: 10.1007/s10067-018-3983.
    PubMed     Text format     Abstract available
    
    
    
38. YU X, Zhang L, Wang L, Lu W, et al
    MRI assessment of erosion repair in patients with long-standing rheumatoid arthritis receiving double-filtration plasmapheresis in addition to leflunomide and methotrexate: a randomized controlled trial.
    Clin Rheumatol. 2018 Jan 8. pii: 10.1007/s10067-017-3956.
    PubMed     Text format     Abstract available
    
    
    
39. RONGEN GA, van Ingen I, Kok M, Vonkeman H, et al
    Vasodilator function worsens after cessation of tumour necrosis factor inhibitor therapy in patients with rheumatoid arthritis only if a flare occurs.
    Clin Rheumatol. 2018 Jan 7. pii: 10.1007/s10067-017-3961.
    PubMed     Text format     Abstract available
    
    
    
40. CHEN MH, Lee MH, Liao HT, Chen WS, et al
    Health-related quality of life outcomes in patients with rheumatoid arthritis and ankylosing spondylitis after tapering biologic treatment.
    Clin Rheumatol. 2018 Jan 6. pii: 10.1007/s10067-017-3965.
    PubMed     Text format     Abstract available
    
    
    
41. LU C, Xu K, Guo H, Peng K, et al
    The relationship of PADI4_94 polymorphisms with the morbidity of rheumatoid arthritis in Caucasian and Asian populations: a meta-analysis and system review.
    Clin Rheumatol. 2018 Jan 4. pii: 10.1007/s10067-017-3964.
    PubMed     Text format     Abstract available
    
    
    
42. CONN DL, Tiliakos A, Bao G, Li S, et al
    Effect of daily low dose prednisone, divided or single daily dose, in the treatment of African Americans with early rheumatoid arthritis.
    Clin Rheumatol. 2018 Jan 3. pii: 10.1007/s10067-017-3943.
    PubMed     Text format     Abstract available
    
    
    December 2017
43. SANTOS AM, Saldarriaga EL, Giraldo-Bustos R, Ballesteros-Munoz JG, et al
    Dickkopf 1 protein circulating levels as a possible biomarker of functional disability and chronic damage in patients with rheumatoid arthritis.
    Clin Rheumatol. 2017 Dec 27. pii: 10.1007/s10067-017-3957.
    PubMed     Text format     Abstract available
    
    
    
44. KUUSALO L, Puolakka K, Kautiainen H, Karjalainen A, et al
    High burden of adverse events is associated with reduced remission rates in early rheumatoid arthritis.
    Clin Rheumatol. 2017 Dec 26. pii: 10.1007/s10067-017-3958.
    PubMed     Text format     Abstract available
    
    
    
45. GALARZA-DELGADO DA, Villegas Gonzalez MJ, Riega Torres J, Soto-Galindo GA, et al
    Early hearing loss detection in rheumatoid arthritis and primary Sjogren syndrome using extended high frequency audiometry.
    Clin Rheumatol. 2017 Dec 22. pii: 10.1007/s10067-017-3959.
    PubMed     Text format     Abstract available
    
    
    
46. RAMIREZ-FLORENCIO M, Jimenez-Morales S, Barbosa-Cobos RE, Lopez-Cano DJ, et al
    High frequency of mutant thiopurine S-methyltransferase genotypes in Mexican patients with systemic lupus erythematosus and rheumatoid arthritis.
    Clin Rheumatol. 2017 Dec 20. pii: 10.1007/s10067-017-3955.
    PubMed     Text format     Abstract available
    
    
    
47. BARBOSA-COBOS RE, Lugo-Zamudio G, Flores-Estrada J, Becerril-Mendoza LT, et al
    Serum substance P: an indicator of disease activity and subclinical inflammation in rheumatoid arthritis.
    Clin Rheumatol. 2017 Dec 18. pii: 10.1007/s10067-017-3929.
    PubMed     Text format     Abstract available
    
    
    
48. CARRANZA-LEON D, Octaria R, Ormseth MJ, Oeser A, et al
    Association between urinary sodium and potassium excretion and blood pressure and inflammation in patients with rheumatoid arthritis.
    Clin Rheumatol. 2017 Dec 14. pii: 10.1007/s10067-017-3935.
    PubMed     Text format     Abstract available
    
    
    
49. CURTIS JR, Trivedi M, Haraoui B, Emery P, et al
    Defining and characterizing sustained remission in patients with rheumatoid arthritis.
    Clin Rheumatol. 2017 Dec 9. pii: 10.1007/s10067-017-3923.
    PubMed     Text format     Abstract available
    
    
    
50. EUDY AM, McDaniel G, Clowse MEB
    Pregnancy in rheumatoid arthritis: a retrospective study.
    Clin Rheumatol. 2017 Dec 8. pii: 10.1007/s10067-017-3939.
    PubMed     Text format    
    
    
    November 2017
51. WANG L, Tan W, Wang F, Shen Y, et al
    Artery compliance in patients with rheumatoid arthritis: results from a case-control study.
    Clin Rheumatol. 2017 Nov 13. doi: 10.1007/s10067-017-3899.
    PubMed     Text format     Abstract available
    
    
    
52. HASSINE HB, Sghiri R, Chabchoub E, Boumiza A, et al
    IRAK2 is associated with susceptibility to rheumatoid arthritis.
    Clin Rheumatol. 2017 Nov 11. doi: 10.1007/s10067-017-3906.
    PubMed     Text format     Abstract available
    
    
    
53. CHARLES-SCHOEMAN C, Meriwether D, Lee YY, Shahbazian A, et al
    High levels of oxidized fatty acids in HDL are associated with impaired HDL function in patients with active rheumatoid arthritis.
    Clin Rheumatol. 2017 Nov 11. doi: 10.1007/s10067-017-3896.
    PubMed     Text format     Abstract available
    
    
    
54. ZHU H, Li R, Da Z, Bi L, et al
    Remission assessment of rheumatoid arthritis in daily practice in China: a cross-sectional observational study.
    Clin Rheumatol. 2017 Nov 7. doi: 10.1007/s10067-017-3850.
    PubMed     Text format     Abstract available
    
    
    
55. HE Y, Liu C, Zeng Z, Ye W, et al
    Red blood cell distribution width: a potential laboratory parameter for monitoring inflammation in rheumatoid arthritis.
    Clin Rheumatol. 2017 Nov 3. doi: 10.1007/s10067-017-3871.
    PubMed     Text format     Abstract available
    
    
    
56. BATUN-GARRIDO JAJ, Salas-Magana M, Juarez-Rojop IE
    Association between leptin and IL-6 concentrations with cardiovascular risk in patients with rheumatoid arthritis.
    Clin Rheumatol. 2017 Nov 3. doi: 10.1007/s10067-017-3897.
    PubMed     Text format     Abstract available
    
    
    
57. MASSONE F, Martinez ME, Pascual-Ramos V, Quintana R, et al
    Educational website incorporating rheumatoid arthritis patient needs for Latin American and Caribbean countries.
    Clin Rheumatol. 2017 Nov 2. doi: 10.1007/s10067-017-3866.
    PubMed     Text format     Abstract available
    
    
    
58. BISI MC, do Prado AD, Piovesan DM, Bredemeier M, et al
    Correction to: Ultrasound resistive index, power Doppler, and clinical parameters in established rheumatoid arthritis.
    Clin Rheumatol. 2017 Nov 2. doi: 10.1007/s10067-017-3882.
    PubMed     Text format     Abstract available
    
    
    October 2017
59. PU D, Luo J, Wang Y, Ju B, et al
    Prevalence of depression and anxiety in rheumatoid arthritis patients and their associations with serum vitamin D level.
    Clin Rheumatol. 2017 Oct 23. doi: 10.1007/s10067-017-3874.
    PubMed     Text format     Abstract available
    
    
    
60. NADA DW, El Morsy S, Abu-Zaid MH, Aboelhawa MA, et al
    The role of microalbuminuria as a predictor of subclinical cardiovascular events in rheumatoid arthritis patients and its relation to disease activity.
    Clin Rheumatol. 2017 Oct 23. doi: 10.1007/s10067-017-3849.
    PubMed     Text format     Abstract available
    
    
    
61. FU Q, Bai Y, Liu Y, Zhou J, et al
    The serum level and significance of lysyl oxidase-like 2 in patients with rheumatoid arthritis-associated interstitial lung disease.
    Clin Rheumatol. 2017 Oct 19. doi: 10.1007/s10067-017-3878.
    PubMed     Text format     Abstract available
    
    
    
62. OLARU L, Soong L, Dhillon S, Yacyshyn E, et al
    Coexistent rheumatoid arthritis and gout: a case series and review of the literature.
    Clin Rheumatol. 2017 Oct 12. doi: 10.1007/s10067-017-3856.
    PubMed     Text format     Abstract available
    
    
    
63. XING R, Sun L, Wu D, Jin Y, et al
    Autoantibodies against interleukin-21 correlate with disease activity in patients with rheumatoid arthritis.
    Clin Rheumatol. 2017 Oct 10. doi: 10.1007/s10067-017-3862.
    PubMed     Text format     Abstract available
    
    
    
64. JAFRI K, Ogdie A, Qasim A, Patterson SL, et al
    Discordance of the Framingham cardiovascular risk score and the 2013 American College of Cardiology/American Heart Association risk score in systemic lupus erythematosus and rheumatoid arthritis.
    Clin Rheumatol. 2017 Oct 9. doi: 10.1007/s10067-017-3860.
    PubMed     Text format     Abstract available
    
    
    
65. GO DJ, Shin K, Baek HJ, Kang SW, et al
    Pivotal factors for successful withdrawal of nonsteroidal anti-inflammatory drugs in rheumatoid arthritis patients in remission or with low-disease activity.
    Clin Rheumatol. 2017 Oct 8. doi: 10.1007/s10067-017-3863.
    PubMed     Text format     Abstract available
    
    
    
66. IANNONE F, Ferraccioli G, Sinigaglia L, Favalli EG, et al
    Real-world experience of tocilizumab in rheumatoid arthritis: sub-analysis of data from the Italian biologics' register GISEA.
    Clin Rheumatol. 2017 Oct 5. doi: 10.1007/s10067-017-3846.
    PubMed     Text format     Abstract available
    
    
    
67. BAE SC, Lee YH
    Comparative efficacy and tolerability of monotherapy with leflunomide or tacrolimus for the treatment of rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials.
    Clin Rheumatol. 2017 Oct 1. doi: 10.1007/s10067-017-3857.
    PubMed     Text format     Abstract available
    
    
    September 2017
68. MORTADA MA, Abdelwhab SM, Elgawish MH
    Intra-articular methotrexate versus corticosteroid injections in medium-sized joints of rheumatoid arthritis patients-an intervention study.
    Clin Rheumatol. 2017 Sep 30. doi: 10.1007/s10067-017-3843.
    PubMed     Text format     Abstract available
    
    
    
69. ROMAN-FERNANDEZ IV, Sanchez-Zuno GA, Padilla-Gutierrez JR, Cerpa-Cruz S, et al
    The 3'-UTR (CA)n microsatellite on CD40LG gene as a possible genetic marker for rheumatoid arthritis in Mexican population: impact on CD40LG mRNA expression.
    Clin Rheumatol. 2017 Sep 30. doi: 10.1007/s10067-017-3853.
    PubMed     Text format     Abstract available
    
    
    
70. LV M, Miao J, Zhao P, Luo X, et al
    CD147-mediated chemotaxis of CD4+CD161+ T cells may contribute to local inflammation in rheumatoid arthritis.
    Clin Rheumatol. 2017 Sep 25. doi: 10.1007/s10067-017-3800.
    PubMed     Text format     Abstract available
    
    
    
71. LIU XZ, Gao Y, Fan J, Xu X, et al
    Metabolic abnormalities in rheumatoid arthritis patients with comorbid diabetes mellitus.
    Clin Rheumatol. 2017 Sep 24. doi: 10.1007/s10067-017-3847.
    PubMed     Text format     Abstract available
    
    
    
72. HATTORI Y, Kida D, Kaneko A
    Normal serum matrix metalloproteinase-3 levels can be used to predict clinical remission and normal physical function in patients with rheumatoid arthritis.
    Clin Rheumatol. 2017 Sep 22. doi: 10.1007/s10067-017-3829.
    PubMed     Text format     Abstract available
    
    
    
73. HANAOKA BY, Ormseth MJ, Michael Stein C, Banerjee D, et al
    Secretory sphingomyelinase (S-SMase) activity is elevated in patients with rheumatoid arthritis.
    Clin Rheumatol. 2017 Sep 15. doi: 10.1007/s10067-017-3824.
    PubMed     Text format     Abstract available
    
    
    
74. MOHAMMED AT, Khattab M, Ahmed AM, Turk T, et al
    The therapeutic effect of probiotics on rheumatoid arthritis: a systematic review and meta-analysis of randomized control trials.
    Clin Rheumatol. 2017 Sep 15. doi: 10.1007/s10067-017-3814.
    PubMed     Text format     Abstract available
    
    
    
75. LU T, Zong M, Fan S, Lu Y, et al
    Thioredoxin 1 is associated with the proliferation and apoptosis of rheumatoid arthritis fibroblast-like synoviocytes.
    Clin Rheumatol. 2017 Sep 15. doi: 10.1007/s10067-017-3832.
    PubMed     Text format     Abstract available
    
    
    
76. HUANG AF, Su LC, Jia H, Liu Y, et al
    No association of single nucleotide polymorphisms within H19 and HOX transcript antisense RNA (HOTAIR) with genetic susceptibility to systemic lupus erythematosus, rheumatoid arthritis, and primary Sjogren's syndrome in a Chinese Han population.
    Clin Rheumatol. 2017 Sep 15. doi: 10.1007/s10067-017-3833.
    PubMed     Text format     Abstract available
    
    
    
77. PIERINGER H, Hintenberger R, Pohanka E, Steinwender C, et al
    RABBIT risk score and ICU admission due to infection in patients with rheumatoid arthritis.
    Clin Rheumatol. 2017 Sep 14. doi: 10.1007/s10067-017-3825.
    PubMed     Text format     Abstract available
    
    
    
78. DU J, Chen S, Shi J, Zhu X, et al
    The association between the lymphocyte-monocyte ratio and disease activity in rheumatoid arthritis.
    Clin Rheumatol. 2017 Sep 14. doi: 10.1007/s10067-017-3815.
    PubMed     Text format     Abstract available
    
    
    
79. SAKTHISWARY R, Rajalingam S, Hussein H, Sridharan R, et al
    Cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis and its correlation with sonographic knee cartilage thickness and disease activity.
    Clin Rheumatol. 2017 Sep 9. doi: 10.1007/s10067-017-3817.
    PubMed     Text format     Abstract available
    
    
    
80. REN J, Sun L, Zhao J
    Meta-analysis: diagnostic accuracy of antibody against peptidylarginine deiminase 4 by ELISA for rheumatoid arthritis.
    Clin Rheumatol. 2017 Sep 8. doi: 10.1007/s10067-017-3809.
    PubMed     Text format     Abstract available
    
    
    
81. MORI S, Yoshitama T, Hirakata N, Ueki Y, et al
    Prevalence of and factors associated with renal dysfunction in rheumatoid arthritis patients: a cross-sectional study in community hospitals.
    Clin Rheumatol. 2017 Sep 7. doi: 10.1007/s10067-017-3804.
    PubMed     Text format     Abstract available
    
    
    
82. AHLUWALIA V, Rampakakis E, Movahedi M, Cesta A, et al
    Predictors of patient decision to discontinue anti-rheumatic medication in patients with rheumatoid arthritis: results from the Ontario best practices research initiative.
    Clin Rheumatol. 2017 Sep 6. doi: 10.1007/s10067-017-3805.
    PubMed     Text format     Abstract available
    
    
    
83. GONG X, Xu SQ, Wu Y, Ma CC, et al
    Elevated serum 14-3-3eta protein may be helpful for diagnosis of early rheumatoid arthritis associated with secondary osteoporosis in Chinese population.
    Clin Rheumatol. 2017 Sep 5. doi: 10.1007/s10067-017-3807.
    PubMed     Text format     Abstract available
    
    
    
84. ZHANG F, Ma C
    Comparison of the effectiveness on intra-articular and subcutaneous TNF inhibitor in rheumatoid arthritis patients.
    Clin Rheumatol. 2017 Sep 4. doi: 10.1007/s10067-017-3806.
    PubMed     Text format     Abstract available
    
    
    August 2017
85. HAMMAM N, Gheita TA
    Impact of secondhand smoking on disease activity in women with rheumatoid arthritis.
    Clin Rheumatol. 2017 Aug 25. doi: 10.1007/s10067-017-3795.
    PubMed     Text format     Abstract available
    
    
    
86. SANTOS-MORENO P, Caballero-Uribe CV, Massardo ML, Maldonado CG, et al
    Systematic and progressive implementation of the centers of excellence for rheumatoid arthritis: a methodological proposal.
    Clin Rheumatol. 2017 Aug 24. doi: 10.1007/s10067-017-3790.
    PubMed     Text format     Abstract available
    
    
    
87. SUN X, Deng X, Geng Y, Ji L, et al
    A simplified and validated ultrasound scoring system to evaluate synovitis of bilateral wrists and hands in patients with rheumatoid arthritis.
    Clin Rheumatol. 2017 Aug 22. doi: 10.1007/s10067-017-3785.
    PubMed     Text format     Abstract available
    
    
    
88. JEAN S, Hudson M, Gamache P, Bessette L, et al
    Temporal trends in prevalence, incidence, and mortality for rheumatoid arthritis in Quebec, Canada: a population-based study.
    Clin Rheumatol. 2017 Aug 21. doi: 10.1007/s10067-017-3796.
    PubMed     Text format     Abstract available
    
    
    
89. HATTORI Y, Kida D, Kaneko A
    Comparison of physical function in early rheumatoid arthritis patients treated with biologics for 1 year who achieved clinical remission or low disease activity.
    Clin Rheumatol. 2017 Aug 19. doi: 10.1007/s10067-017-3791.
    PubMed     Text format     Abstract available
    
    
    
90. D'AGOSTINO MA, Alten R, Mysler E, Le Bars M, et al
    Body mass index and clinical response to intravenous or subcutaneous abatacept in patients with rheumatoid arthritis.
    Clin Rheumatol. 2017 Aug 18. doi: 10.1007/s10067-017-3788.
    PubMed     Text format     Abstract available
    
    
    
91. WANG B, Tang Y, Sun X, Ouyang X, et al
    Increased IL-6 expression on THP-1 by IL-34 stimulation up-regulated rheumatoid arthritis Th17 cells.
    Clin Rheumatol. 2017 Aug 15. doi: 10.1007/s10067-017-3746.
    PubMed     Text format     Abstract available
    
    
    
92. MUELLER RB, Graninger W, Sidiropoulos P, Goger C, et al
    Median time to low disease activity is shorter in tocilizumab combination therapy with csDMARDs as compared to tocilizumab monotherapy in patients with active rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: sub-analysi
    Clin Rheumatol. 2017 Aug 3. doi: 10.1007/s10067-017-3779.
    PubMed     Text format     Abstract available
    
    
    July 2017
93. GAUBITZ M, Gottl KH, Behmer O, Lippe R, et al
    Etanercept is effective as monotherapy or in combination with methotrexate in rheumatoid arthritis: subanalysis of an observational study.
    Clin Rheumatol. 2017 Jul 30. doi: 10.1007/s10067-017-3757.
    PubMed     Text format     Abstract available
    
    
    
94. JAHID M, Rehan-Ul-Haq, Jha PK, Chawla D, et al
    Tumor necrosis factor-alpha -308 polymorphism in North Indian rheumatoid arthritis patients and association with mRNA and serum TNF-alpha.
    Clin Rheumatol. 2017 Jul 27. doi: 10.1007/s10067-017-3774.
    PubMed     Text format     Abstract available
    
    
    
95. FENG ZT, Xu J, He GC, Cai SJ, et al
    A systemic review and meta-analysis of the clinical efficacy and safety of total glucosides of peony combined with methotrexate in rheumatoid arthritis.
    Clin Rheumatol. 2017 Jul 27. doi: 10.1007/s10067-017-3770.
    PubMed     Text format     Abstract available
    
    
    
96. PALAMAR D, Er G, Terlemez R, Ustun I, et al
    Disease activity, handgrip strengths, and hand dexterity in patients with rheumatoid arthritis.
    Clin Rheumatol. 2017 Jul 18. doi: 10.1007/s10067-017-3756.
    PubMed     Text format     Abstract available
    
    
    
97. HARROLD LR, John A, Best J, Zlotnick S, et al
    Impact of rituximab on patient-reported outcomes in patients with rheumatoid arthritis from the US Corrona Registry.
    Clin Rheumatol. 2017 Jul 17. doi: 10.1007/s10067-017-3742.
    PubMed     Text format     Abstract available
    
    
    
98. WANG P, Li S, Liu LN, Lv TT, et al
    Circulating osteoprotegerin levels are elevated in rheumatoid arthritis: a systematic review and meta-analysis.
    Clin Rheumatol. 2017 Jul 11. doi: 10.1007/s10067-017-3747.
    PubMed     Text format     Abstract available
    
    
    
99. BOLETO G, Drame M, Lambrecht I, Eschard JP, et al
    Disease-modifying anti-rheumatic drug effect of denosumab on radiographic progression in rheumatoid arthritis: a systematic review of the literature.
    Clin Rheumatol. 2017 Jul 1. doi: 10.1007/s10067-017-3722.
    PubMed     Text format     Abstract available
    
    
    June 2017
100. HANNAWI S, AlSalmi I, Moller I, Naredo E, et al
     Uric acid is independent cardiovascular risk factor, as manifested by increased carotid intima-media thickness in rheumatoid arthritis patients.
     Clin Rheumatol. 2017 Jun 30. doi: 10.1007/s10067-017-3737.
     PubMed     Text format     Abstract available
     
     
     
101. BAPTISTA TSA, Petersen LE, Molina JK, de Nardi T, et al
     Autoantibodies against myelin sheath and S100beta are associated with cognitive dysfunction in patients with rheumatoid arthritis.
     Clin Rheumatol. 2017 Jun 27. doi: 10.1007/s10067-017-3724.
     PubMed     Text format     Abstract available
     
     
     
102. BACALAO EJ, Greene GJ, Beaumont JL, Eisenstein A, et al
     Standardizing and personalizing the treat to target (T2T) approach for rheumatoid arthritis using the Patient-Reported Outcomes Measurement Information System (PROMIS): baseline findings on patient-centered treatment priorities.
     Clin Rheumatol. 2017 Jun 26. doi: 10.1007/s10067-017-3731.
     PubMed     Text format     Abstract available
     
     
     
103. HAN J, Geng Y, Deng X, Zhang Z, et al
     Risk factors of flare in rheumatoid arthritis patients with both clinical and ultrasonographic remission: a retrospective study from China.
     Clin Rheumatol. 2017 Jun 22. doi: 10.1007/s10067-017-3736.
     PubMed     Text format     Abstract available
     
     
     
104. SYNGLE A, Kaur S, Verma I, Syngle T, et al
     Cost-effective analysis of disease-modifying anti-rheumatic drugs in rheumatoid arthritis.
     Clin Rheumatol. 2017 Jun 21. doi: 10.1007/s10067-017-3725.
     PubMed     Text format     Abstract available
     
     
     
105. FASSIO A, Idolazzi L, Viapiana O, Benini C, et al
     In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls.
     Clin Rheumatol. 2017 Jun 20. doi: 10.1007/s10067-017-3734.
     PubMed     Text format     Abstract available
     
     
     
106. XIE X, Li F, Li S, Tian J, et al
     Application of omics in predicting anti-TNF efficacy in rheumatoid arthritis.
     Clin Rheumatol. 2017 Jun 10. doi: 10.1007/s10067-017-3639.
     PubMed     Text format     Abstract available
     
     
     
107. ROJAS-SERRANO J, Herrera-Bringas D, Perez-Roman DI, Perez-Dorame R, et al
     Rheumatoid arthritis-related interstitial lung disease (RA-ILD): methotrexate and the severity of lung disease are associated to prognosis.
     Clin Rheumatol. 2017 Jun 6. doi: 10.1007/s10067-017-3707.
     PubMed     Text format     Abstract available
     
     
     
108. SAG S, Sag MS, Tekeoglu I, Kamanli A, et al
     Nailfold videocapillaroscopy results in patients with rheumatoid arthritis.
     Clin Rheumatol. 2017 Jun 4. doi: 10.1007/s10067-017-3696.
     PubMed     Text format     Abstract available
     
     
     
109. VOS I, Van Mol C, Trouw LA, Mahler M, et al
     Anti-citrullinated protein antibodies in the diagnosis of rheumatoid arthritis (RA): diagnostic performance of automated anti-CCP-2 and anti-CCP-3 antibodies assays.
     Clin Rheumatol. 2017 Jun 3. doi: 10.1007/s10067-017-3684.
     PubMed     Text format     Abstract available
     
     
     
110. STOJANOVIC S, Bojana Stamenkovic, Stoimenov TJ, Nedovic J, et al
     Association of tumor necrosis factor-alpha (G-308A) genetic variant with matrix metalloproteinase-9 activity and joint destruction in early rheumatoid arthritis.
     Clin Rheumatol. 2017 Jun 1. doi: 10.1007/s10067-017-3699.
     PubMed     Text format     Abstract available
     
     
     May 2017
111. ROBUSTILLO-VILLARINO M, Alegre-Sancho JJ, Rodilla-Sala E, Corrales A, et al
     Pulse wave velocity and augmentation index are not independently associated with carotid atherosclerosis in patients with rheumatoid arthritis.
     Clin Rheumatol. 2017 May 25. doi: 10.1007/s10067-017-3680.
     PubMed     Text format     Abstract available
     
     
     
112. JAUREGUI JJ, Paul Hovis J, Ashfaq Hasan S
     Characteristics of rheumatoid arthritis patients undergoing reverse shoulder arthroplasty.
     Clin Rheumatol. 2017 May 24. doi: 10.1007/s10067-017-3679.
     PubMed     Text format     Abstract available
     
     
     
113. EISSA M, El Shafey A, Hammad M
     Comparison between different disease activity scores in rheumatoid arthritis: an Egyptian multicenter study.
     Clin Rheumatol. 2017 May 22. doi: 10.1007/s10067-017-3674.
     PubMed     Text format     Abstract available
     
     
     
114. WANG X, Ma C, Li P, Zhao F, et al
     Effects of iguratimod on the levels of circulating regulators of bone remodeling and bone remodeling markers in patients with rheumatoid arthritis.
     Clin Rheumatol. 2017 May 4. doi: 10.1007/s10067-017-3668.
     PubMed     Text format     Abstract available
     
     
     
115. STRAUB RH, Ehrenstein B, Gunther F, Rauch L, et al
     Increased extracellular water measured by bioimpedance and by increased serum levels of atrial natriuretic peptide in RA patients-signs of volume overload.
     Clin Rheumatol. 2017;36:1041-1051.
     PubMed     Text format     Abstract available
     
     
     April 2017
116. RAHNE T, Clauss F, Plontke SK, Keysser G, et al
     Prevalence of hearing impairment in patients with rheumatoid arthritis, granulomatosis with polyangiitis (GPA, Wegener's granulomatosis), or systemic lupus erythematosus.
     Clin Rheumatol. 2017 Apr 28. doi: 10.1007/s10067-017-3651.
     PubMed     Text format     Abstract available
     
     
     
117. SHIMIZU Y, Nakajima A, Inoue E, Shidara K, et al
     Characteristics and risk factors of lymphoproliferative disorders among patients with rheumatoid arthritis concurrently treated with methotrexate: a nested case-control study of the IORRA cohort.
     Clin Rheumatol. 2017 Apr 28. doi: 10.1007/s10067-017-3634.
     PubMed     Text format     Abstract available
     
     
     
118. ANYFANTI P, Triantafyllou A, Gkaliagkousi E, Triantafyllou G, et al
     Subendocardial viability ratio in patients with rheumatoid arthritis: comparison with healthy controls and identification of prognostic factors.
     Clin Rheumatol. 2017 Apr 28. doi: 10.1007/s10067-017-3659.
     PubMed     Text format     Abstract available
     
     
     
119. DONISAN T, Bojinca VC, Dobrin MA, Balanescu DV, et al
     The relationship between disease activity, quality of life, and personality types in rheumatoid arthritis and ankylosing spondylitis patients.
     Clin Rheumatol. 2017 Apr 27. doi: 10.1007/s10067-017-3654.
     PubMed     Text format     Abstract available
     
     
     
120. SON KM, Lee SY, Seo YI, Choi JE, et al
     Contribution of subjective Disease Activity Score 28 (DAS28) components to the response to treatment of rheumatoid arthritis.
     Clin Rheumatol. 2017 Apr 27. doi: 10.1007/s10067-017-3628.
     PubMed     Text format     Abstract available
     
     
     
121. EL-LEBEDY D, Raslan H, Ibrahim A, Ashmawy I, et al
     Association of STAT4 rs7574865 and PTPN22 rs2476601 polymorphisms with rheumatoid arthritis and non-systemically reacting antibodies in Egyptian patients.
     Clin Rheumatol. 2017 Apr 19. doi: 10.1007/s10067-017-3632.
     PubMed     Text format     Abstract available
     
     
     
122. TAKEUCHI H, Kawasaki T, Shigematsu K, Kawamura K, et al
     Neutrophil extracellular traps in neuropathy with anti-neutrophil cytoplasmic autoantibody-associated microscopic polyangiitis.
     Clin Rheumatol. 2017;36:913-917.
     PubMed     Text format     Abstract available
     
     
     March 2017
123. CUOMO G, D'Abrosca V, Iacono D, Pantano I, et al
     Erratum to: The conversion rate of tuberculosis screening tests during biological therapies in patients with rheumatoid arthritis.
     Clin Rheumatol. 2017 Mar 28. doi: 10.1007/s10067-017-3614.
     PubMed     Text format    
     
     
     
124. MURALIDHARAN N, Misra DP, Jain VK, Negi VS, et al
     Effect of thymidylate synthase (TYMS) gene polymorphisms with methotrexate treatment outcome in south Indian Tamil patients with rheumatoid arthritis.
     Clin Rheumatol. 2017 Mar 27. doi: 10.1007/s10067-017-3608.
     PubMed     Text format     Abstract available
     
     
     
125. RAMIREZ-PEREZ S, Salazar-Paramo M, Pineda-Monjaras S, De la Cruz-Mosso U, et al
     Association of 86 bp variable number of tandem repeat (VNTR) polymorphism of interleukin-1 receptor antagonist (IL1RN) with susceptibility and clinical activity in rheumatoid arthritis.
     Clin Rheumatol. 2017 Mar 25. doi: 10.1007/s10067-017-3610.
     PubMed     Text format     Abstract available
     
     
     
126. LI C, Wang XR, Ji HJ, Zhang XY, et al
     Cardiovascular disease in rheumatoid arthritis: medications and risk factors in China.
     Clin Rheumatol. 2017 Mar 24. doi: 10.1007/s10067-017-3596.
     PubMed     Text format     Abstract available
     
     
     February 2017
127. PARK DJ, Choi SJ, Shin K, Kim HA, et al
     Switching profiles in a population-based cohort of rheumatoid arthritis receiving biologic therapy: results from the KOBIO registry.
     Clin Rheumatol. 2017 Feb 27. doi: 10.1007/s10067-017-3584.
     PubMed     Text format     Abstract available
     
     
     
128. ZHANG Y, Li H, Wu N, Dong X, et al
     Retrospective study of the clinical characteristics and risk factors of rheumatoid arthritis-associated interstitial lung disease.
     Clin Rheumatol. 2017 Feb 12. doi: 10.1007/s10067-017-3561.
     PubMed     Text format     Abstract available
     
     
     
129. BOMAN A, Kokkonen H, Arlestig L, Berglin E, et al
     Receptor activator of nuclear factor kappa-B ligand (RANKL) but not sclerostin or gene polymorphisms is related to joint destruction in early rheumatoid arthritis.
     Clin Rheumatol. 2017 Feb 11. doi: 10.1007/s10067-017-3570.
     PubMed     Text format     Abstract available
     
     
     
130. GALARZA-DELGADO DA, Azpiri-Lopez JR, Colunga-Pedraza IJ, Cardenas-de la Garza JA, et al
     Assessment of six cardiovascular risk calculators in Mexican mestizo patients with rheumatoid arthritis according to the EULAR 2015/2016 recommendations for cardiovascular risk management.
     Clin Rheumatol. 2017 Feb 1. doi: 10.1007/s10067-017-3551.
     PubMed     Text format     Abstract available
     
     
     
131. XIAO F
     Neuromyotonia as an unusual neurological complication of primary Sjogren's syndrome: case report and literature review.
     Clin Rheumatol. 2017;36:481-484.
     PubMed     Text format     Abstract available
     
     
     
132. CIPRIANI P, Berardicurti O, Masedu F, D'Onofrio F, et al
     Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study.
     Clin Rheumatol. 2017;36:251-260.
     PubMed     Text format     Abstract available
     
     
     
133. AKDEMIR G, Markusse IM, Goekoop-Ruiterman YP, Steup-Beekman GM, et al
     Rheumatologists' adherence to a disease activity score steered treatment protocol in early arthritis patients is less if the target is remission.
     Clin Rheumatol. 2017;36:317-326.
     PubMed     Text format     Abstract available
     
     
     January 2017
134. LIU JH, Ng MY, Cheung T, Chung HY, et al
     Ten-year progression of coronary artery, carotid artery, and aortic calcification in patients with rheumatoid arthritis.
     Clin Rheumatol. 2017 Jan 26. doi: 10.1007/s10067-016-3536.
     PubMed     Text format     Abstract available
     
     
     
135. ISOGAI T, Matsui H, Tanaka H, Yokogawa N, et al
     Treatments and in-hospital mortality in acute myocardial infarction patients with rheumatoid arthritis: a nationwide retrospective cohort study in Japan.
     Clin Rheumatol. 2017 Jan 26. doi: 10.1007/s10067-017-3555.
     PubMed     Text format     Abstract available
     
     
     
136. ANDREWS JS, Trupin L, Yelin EH, Hough CL, et al
     Frailty and reduced physical function go hand in hand in adults with rheumatoid arthritis: a US observational cohort study.
     Clin Rheumatol. 2017 Jan 23. doi: 10.1007/s10067-017-3541.
     PubMed     Text format     Abstract available
     
     
     
137. ALPIZAR-RODRIGUEZ D, Brulhart L, Mueller RB, Moller B, et al
     The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis.
     Clin Rheumatol. 2017 Jan 21. doi: 10.1007/s10067-017-3547.
     PubMed     Text format     Abstract available
     
     
     
138. MONTI S, Klersy C, Gorla R, Sarzi-Puttini P, et al
     Factors influencing the choice of first- and second-line biologic therapy for the treatment of rheumatoid arthritis: real-life data from the Italian LORHEN Registry.
     Clin Rheumatol. 2017 Jan 5. doi: 10.1007/s10067-016-3528.
     PubMed     Text format     Abstract available
     
     
     
139. LIU C, Zhang H, Yao G, Hu Y, et al
     Characteristics of primary Sjogren's syndrome patients with IgG4 positive plasma cells infiltration in the labial salivary glands.
     Clin Rheumatol. 2017;36:83-88.
     PubMed     Text format     Abstract available
     
     
     
140. MUELLER RB, Reshiti N, Kaegi T, Finckh A, et al
     Does addition of glucocorticoids to the initial therapy influence the later course of the disease in patients with early RA? Results from the Swiss prospective observational registry (SCQM).
     Clin Rheumatol. 2017;36:59-66.
     PubMed     Text format     Abstract available
     
     
     
141. ITO T, Tamura N, Okuda S, Tada K, et al
     Elevated serum levels of soluble CD146 in patients with systemic sclerosis.
     Clin Rheumatol. 2017;36:119-124.
     PubMed     Text format     Abstract available
     
     
     December 2016
142. CHEUNG PP, Lahiri M, March L, Gossec L, et al
     Patient-reported outcomes in Asia: evaluation of the properties of the Rheumatoid Arthritis Impact of Disease (RAID) score in multiethnic Asian patients with rheumatoid arthritis.
     Clin Rheumatol. 2016 Dec 30. doi: 10.1007/s10067-016-3522.
     PubMed     Text format     Abstract available
     
     
     
143. UNRIZA-PUIN S, Bautista-Molano W, Lafaurie GI, Valle-Onate R, et al
     Are obesity, ACPAs and periodontitis conditions that influence the risk of developing rheumatoid arthritis in first-degree relatives?
     Clin Rheumatol. 2016 Dec 28. doi: 10.1007/s10067-016-3519.
     PubMed     Text format     Abstract available
     
     
     
144. MUNOZ JG, Giraldo RB, Santos AM, Bello-Gualteros JM, et al
     Correlation between rapid-3, DAS28, CDAI and SDAI as a measure of disease activity in a cohort of Colombian patients with rheumatoid arthritis.
     Clin Rheumatol. 2016 Dec 24. doi: 10.1007/s10067-016-3521.
     PubMed     Text format     Abstract available
     
     
     
145. BISI MC, do Prado AD, Piovesan DM, Bredemeier M, et al
     Ultrasound resistive index, power Doppler, and clinical parameters in established rheumatoid arthritis.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
146. 
     Latitude gradient influences the age of onset of rheumatoid arthritis: a worldwide survey.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
147. SCANLON EM, Mankad R, Crowson CS, Kullo IJ, et al
     Cardiovascular risk assessment in patients with rheumatoid arthritis: a correlative study of noninvasive arterial health testing.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
148. LUTEREK-PUSZYNSKA K, Malinowski D, Paradowska-Gorycka A, Safranow K, et al
     CD28, CTLA-4 and CCL5 gene polymorphisms in patients with rheumatoid arthritis.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
149. IANNONE F, Courvoisier DS, Gottenberg JE, Hernandez MV, et al
     Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the "pan-European registry collaboration for abatacept (PANABA).
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
150. BAROUTA G, Katsiari CG, Alexiou I, Liaskos C, et al
     Anti-MCV antibodies predict radiographic progression in Greek patients with very early (<3 months duration) rheumatoid arthritis.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
151. WAKABAYASHI H, Inada H, Nishioka Y, Hasegawa M, et al
     Maintenance of efficacy and safety with subcutaneous golimumab in rheumatoid arthritis patients with low disease activity who previously received TNF inhibitors.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
152. ORNBJERG LM, Ostergaard M, Jensen T, Horslev-Petersen K, et al
     Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab-a substudy of the optimized treatment algorithm in early RA (OPERA) trial.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
153. KIHARA M, Davies R, Kearsley-Fleet L, Watson KD, et al
     Use and effectiveness of tocilizumab among patients with rheumatoid arthritis: an observational study from the British Society for Rheumatology Biologics Register for rheumatoid arthritis.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
154. KABEERDOSS J, Sandhya P, Mandal SK, Gowri M, et al
     High salivary soluble L-selectin and interleukin-7 levels in Asian Indian patients with primary Sjogren's syndrome.
     Clin Rheumatol. 2016;35:3063-3067.
     PubMed     Text format     Abstract available
     
     
     November 2016
155. LENERT A, Lenert P
     Tapering biologics in rheumatoid arthritis: a pragmatic approach for clinical practice.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
156. BASIC Z, Jerkovic I, Kruzic I, Andelinovic S, et al
     Rich but poor: life in the Roman period with extreme rheumatoid arthritis.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
157. HOPKINS AM, Wiese MD, O'Doherty CE, Proudman SM, et al
     Putting recommendations into practice: Australian rheumatologists' opinions on leflunomide use in rheumatoid arthritis.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
158. SHIMADA K, Komiya A, Yokogawa N, Nishino J, et al
     Impact of the size and number of swollen joints on serum C-reactive protein level and erythrocyte sedimentation rate in rheumatoid arthritis: a cross-sectional study in Japan.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
159. NAKAJIMA A, Aoki Y, Sonobe M, Takahashi H, et al
     Serum level of reactive oxygen metabolites (ROM) at 12 weeks of treatment with biologic agents for rheumatoid arthritis is a novel predictor for 52-week remission.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
160. JI L, Deng X, Geng Y, Song Z, et al
     The additional benefit of ultrasonography to 2010 ACR/EULAR classification criteria when diagnosing rheumatoid arthritis in the absence of anti-cyclic citrullinated peptide antibodies.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
161. CHEN HH, Chen DY, Chen YM, Lai KL, et al
     Health-related quality of life and utility: comparison of ankylosing spondylitis, rheumatoid arthritis, and systemic lupus erythematosus patients in Taiwan.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
162. MERDLER-RABINOWICZ R, Tiosano S, Comaneshter D, Cohen AD, et al
     Comorbidity of gout and rheumatoid arthritis in a large population database.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
163. HUSBERG M, Davidson T, Hallert E
     Non-medical costs during the first year after diagnosis in two cohorts of patients with early rheumatoid arthritis, enrolled 10 years apart.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
164. JOHNSON J, Yeter K, Rajbhandary R, Neal R, et al
     Serum progranulin levels in Hispanic rheumatoid arthritis patients treated with TNF antagonists: a prospective, observational study.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
165. CUOMO G, D'Abrsca V, Iacono D, Pantano I, et al
     The conversion rate of tuberculosis screening tests during biological therapies in patients with rheumatoid arthritis.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
166. TANG MW, Koopman FA, Visscher JP, de Hair MJ, et al
     Hormone, metabolic peptide, and nutrient levels in the earliest phases of rheumatoid arthritis-contribution of free fatty acids to an increased cardiovascular risk during very early disease.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     October 2016
167. YANG XK, Li P, Li S, Zhang C, et al
     Genetic variant of IL-10RA and susceptibility to rheumatoid arthritis in a Chinese population.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
168. HIRAI T, Ikeda K, Fujishiro M, Tsushima H, et al
     The effectiveness of new triple combination therapy using synthetic disease-modifying anti-rheumatic drugs with different pharmacological function against rheumatoid arthritis: the verification by an in vitro and clinical study.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
169. LOPPENTHIN K, Esbensen BA, Ostergaard M, Ibsen R, et al
     Welfare costs in patients with rheumatoid arthritis and their partners compared with matched controls: a register-based study.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
170. NARAYAN N, Rigby S, Carlucci F
     Sulfasalazine induced immune thrombocytopenia in a patient with rheumatoid arthritis.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
171. RIZZO R, Farina I, Bortolotti D, Galuppi E, et al
     The dimeric form of HLA-G molecule is associated with the response of early rheumatoid arthritis (ERA) patients to methotrexate.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
172. FLEISCHMANN R, Mease PJ, Schwartzman S, Hwang LJ, et al
     Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by background methotrexate dose group.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
173. ALFONSO-CRISTANCHO R, Armstrong N, Arjunji R, Riemsma R, et al
     Comparative effectiveness of biologics for the management of rheumatoid arthritis: systematic review and network meta-analysis.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
174. CHRISTOPOULOS G, Christopoulou V, Routsias JG, Babionitakis A, et al
     Greek rheumatoid arthritis patients have elevated levels of antibodies against antigens from Proteus mirabilis.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
175. AN Y, Liu T, He D, Wu L, et al
     The usage of biological DMARDs and clinical remission of rheumatoid arthritis in China: a real-world large scale study.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
176. DEODHAR A, Bitman B, Yang Y, Collier DH, et al
     The effect of etanercept on traditional metabolic risk factors for cardiovascular disease in patients with rheumatoid arthritis.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
177. TAN YK, Allen JC Jr, Lye WK, Conaghan PG, et al
     Dichotomous versus semi-quantitative scoring of ultrasound joint inflammation in rheumatoid arthritis using novel individualized joint selection methods.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
178. EL-LEBEDY D, Hussein J, Ashmawy I, Mohammed AM, et al
     Serum level of neopterin is not a marker of disease activity in treated rheumatoid arthritis patients.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
179. TOZ B, Erer B
     Rheumatologic manifestations of primary immunodeficiency diseases: comment on the study by Dimitriades et al.
     Clin Rheumatol. 2016;35:2625.
     PubMed     Text format    
     
     
     September 2016
180. PEHLIVAN S, Aydeniz A, Sever T, Altindag O, et al
     The functional variants of endothelial nitric oxide synthase gene associated with rheumatoid arthritis in Turkish adults.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
181. EL MIEDANY Y, El Gaafary M, Youssef S, Ahmed I, et al
     Optimizing therapy in inflammatory arthritis: prediction of relapse after tapering or stopping treatment for rheumatoid arthritis patients achieving clinical and radiological remission.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
182. MALAVIYA AN
     Methotrexate intolerance in the treatment of rheumatoid arthritis (RA): effect of adding caffeine to the management regimen.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     August 2016
183. HAJIALILO M, Ghorbanihaghjo A, Valaee L, Kolahi S, et al
     A double-blind randomized comparative study of triamcinolone hexacetonide and dexamethasone intra-articular injection for the treatment of knee joint arthritis in rheumatoid arthritis.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
184. KARATAS G, Bal A, Yuceege M, Yalcin E, et al
     The evaluation of sleep quality and response to anti-tumor necrosis factor alpha therapy in rheumatoid arthritis patients.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
185. HE J, Wang Y, Feng M, Zhang X, et al
     Dietary intake and risk of rheumatoid arthritis-a cross section multicenter study.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
186. GIRAUD C, Tatar Z, Soubrier M
     Agranulocytosis under biotherapy in rheumatoid arthritis: three cases hypothesis of parvovirus B19 involvement in agranulocytosis observed under tocilizumab and rituximab for the treatment of rheumatoid arthritis.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
187. MARTIN ES, Schneeberger EE, Aranda FM, Peres SW, et al
     The -2518 A/G polymorphism in the monocyte chemoattractant protein 1 gene (MCP-1) is associated with an increased risk of rheumatoid arthritis in Argentine patients.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
188. LATAR I, Koufany M, Hablot J, Loeuille D, et al
     Association between rheumatoid arthritis and systemic mastocytosis: a case report and literature review.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
189. SHOVMAN O, Tiosano S, Comaneshter D, Cohen AD, et al
     Aortic aneurysm associated with rheumatoid arthritis: a population-based cross-sectional study.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
190. UPALA S, Yong WC, Sanguankeo A
     Association between primary Sjogren's syndrome and pregnancy complications: a systematic review and meta-analysis.
     Clin Rheumatol. 2016;35:1949-55.
     PubMed     Text format     Abstract available
     
     
     
191. JUNG JY, Suh CH, Sohn S, Nam JY, et al
     Elevated high-mobility group B1 levels in active adult-onset Still's disease associated with systemic score and skin rash.
     Clin Rheumatol. 2016;35:1937-42.
     PubMed     Text format     Abstract available
     
     
     
192. DALL'ARA F, Frassi M, Tincani A, Airo P, et al
     A retrospective study of patients with adult-onset Still's disease: is pericarditis a possible predictor for biological disease-modifying anti-rheumatic drugs need?
     Clin Rheumatol. 2016;35:2117-23.
     PubMed     Text format     Abstract available
     
     
     
193. HIDER SL, Blagojevic-Bucknall M, Whittle R, Clarkson K, et al
     What does a primary care annual review for RA include? A national GP survey.
     Clin Rheumatol. 2016;35:2137-8.
     PubMed     Text format    
     
     
     July 2016
194. MECOLI CA, Delev NG, Bingham CO 3rd
     Measuring transaminases in patients with rheumatoid arthritis on weekly methotrexate: does timing of blood testing matter?
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
195. CURTIS JR, Zhang R, Krishnaswami S, Anisfeld A, et al
     Use of a risk characterisation approach to contextualise the safety profile of new rheumatoid arthritis treatments: a case study using tofacitinib.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
196. ZAMORA-LEGOFF JA, Krause ML, Crowson CS, Ryu JH, et al
     Risk of serious infection in patients with rheumatoid arthritis-associated interstitial lung disease.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
197. CEN H, Huang H, Zhang LN, Liu LY, et al
     Associations of methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms with genetic susceptibility to rheumatoid arthritis: a meta-analysis.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
198. IANNONE F, Sinigaglia L, Favalli EG, Sarzi-Puttini P, et al
     Drug survival of adalimumab in patients with rheumatoid arthritis over 10 years in the real-world settings: high rate remission together with normal function ability.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
199. VENTURA-RIOS L, Hernandez-Diaz C, Sanchez-Bringas G, Madrigal-Santillan E, et al
     A descriptive, cross-sectional study characterizing bone erosions in rheumatoid arthritis and gout by ultrasound.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
200. SFRISO P, Priori R, Valesini G, Rossi S, et al
     Adult-onset Still's disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients.
     Clin Rheumatol. 2016;35:1683-9.
     PubMed     Text format     Abstract available
     
     
     
201. NAKAJIMA A, Aoki Y, Sonobe M, Watanabe F, et al
     Relative expression and correlation of tumor necrosis factor-alpha, interferon-gamma, and interleukin-17 in the rheumatoid synovium.
     Clin Rheumatol. 2016;35:1691-7.
     PubMed     Text format     Abstract available
     
     
     
202. LOYOLA-SANCHEZ A, Richardson J, Pelaez-Ballestas I, Alvarez-Nemegyei J, et al
     The impact of arthritis on the physical function of a rural Maya-Yucateco community and factors associated with its prevalence: a cross sectional, community-based study.
     Clin Rheumatol. 2016;35 Suppl 1:25-34.
     PubMed     Text format     Abstract available
     
     
     June 2016
203. PIERINGER H, Danninger K, Puchner R, Hoppe UC, et al
     Urinary albumin excretion in patients with rheumatoid arthritis in a large cross-sectional study.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
204. BHATI M, Bandyopadhyay S
     Efficacy and safety of an anti-CD20 monoclonal antibody (Reditux) for the treatment of patients with moderate to severe rheumatoid arthritis following the failure of conventional synthetic disease-modifying anti-rheumatic drugs.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
205. ZAMORA-LEGOFF JA, Myasoedova E, Matteson EL, Achenbach SJ, et al
     Drug prescribing trends in adults with rheumatoid arthritis: a population-based comparative study from 2005 to 2014.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
206. CIURTIN C, Wyszynski K, Clarke R, Mouyis M, et al
     Ultrasound-detected subclinical inflammation was better reflected by the disease activity score (DAS-28) in patients with suspicion of inflammatory arthritis compared to established rheumatoid arthritis.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
207. EPIS O, Scioscia C, Locaputo A, Cappelli A, et al
     Use of ultrasound in treatment decisions for patients with rheumatoid arthritis: an observational study in Italy.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
208. YANG X, Xiao F, Luo D, Wang G, et al
     Interleukin 12B gene polymorphisms and susceptibility to rheumatoid arthritis: a data synthesis.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
209. MADSEN OR
     Stability of clinical outcome measures in rheumatoid arthritis patients with stable disease defined on the basis of the EULAR response criteria.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
210. DAGAN A, Kogan M, Shoenfeld Y, Segal G, et al
     When uncommon and common coalesce: adult onset Still's disease associated with breast augmentation as part of autoimmune syndrome induced by adjuvants (ASIA).
     Clin Rheumatol. 2016;35:1643-8.
     PubMed     Text format     Abstract available
     
     
     May 2016
211. DURAN-AVELAR MJ, Vibanco-Perez N, Hernandez-Pacheco RR, Castro-Zambrano AD, et al
     STAT4 rs7574865 G/T polymorphism is associated with rheumatoid arthritis and disease activity, but not with anti-CCP antibody levels in a Mexican population.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
212. GALARZA-DELGADO DA, Azpiri-Lopez JR, Colunga-Pedraza IJ, Cardenas-de la Garza JA, et al
     Comparison of statin eligibility according to the Adult Treatment Panel III, ACC/AHA blood cholesterol guideline, and presence of carotid plaque by ultrasound in Mexican mestizo patients with rheumatoid arthritis.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
213. OSIRI M, Wongpiyabovorn J, Sattayasomboon Y, Thammacharoenrach N, et al
     Inflammatory cytokine levels, disease activity, and function of patients with rheumatoid arthritis treated with combined conventional disease-modifying antirheumatic drugs or biologics.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
214. CHEN XX, Li ZG, Wu HX, Zhao DB, et al
     A randomized, controlled trial of efficacy and safety of Anbainuo, a bio-similar etanercept, for moderate to severe rheumatoid arthritis inadequately responding to methotrexate.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
215. ZHANG Y, Yang Y, Bai Y, Yang D, et al
     Clinical characteristics and follow-up analysis of adult-onset Still's disease complicated by hemophagocytic lymphohistiocytosis.
     Clin Rheumatol. 2016;35:1145-51.
     PubMed     Text format     Abstract available
     
     
     
216. UMEDA N, Matsumoto I, Kawaguchi H, Kurashima Y, et al
     Prevalence of soluble peptidylarginine deiminase 4 (PAD4) and anti-PAD4 antibodies in autoimmune diseases.
     Clin Rheumatol. 2016;35:1181-8.
     PubMed     Text format     Abstract available
     
     
     
217. CHEN S, Deng C, Hu C, Li J, et al
     Association of MCP-1-2518A/G polymorphism with susceptibility to autoimmune diseases: a meta-analysis.
     Clin Rheumatol. 2016;35:1169-79.
     PubMed     Text format     Abstract available
     
     
     
218. NEWSUM EC, van der Helm-van Mil AH, Kaptein AA
     Views on clinically suspect arthralgia: a focus group study.
     Clin Rheumatol. 2016;35:1347-52.
     PubMed     Text format     Abstract available
     
     
     
219. NOTA I, Drossaert CH, Taal E, van de Laar MA, et al
     Arthritis patients' motives for (not) wanting to be involved in medical decision-making and the factors that hinder or promote patient involvement.
     Clin Rheumatol. 2016;35:1225-35.
     PubMed     Text format     Abstract available
     
     
     
220. NAKAMURA T, Hirakawa K, Takaoka H, Iyama K, et al
     Dystrophic calcinosis with both a huge calcified mass in the cervical spine and calcification in the chest wall in a patient with rheumatoid overlap syndrome.
     Clin Rheumatol. 2016;35:1403-9.
     PubMed     Text format     Abstract available
     
     
     
221. SCRIVO R, Sauzullo I, Mengoni F, Riccieri V, et al
     The role of interferon-gamma release assays in predicting the emergence of active tuberculosis in the setting of biological treatment: a case report and review of the literature.
     Clin Rheumatol. 2016;35:1383-8.
     PubMed     Text format     Abstract available
     
     
     
222. COZZI A, Papagrigoraki A, Biasi D, Colato C, et al
     Cutaneous manifestations of adult-onset Still's disease: a case report and review of literature.
     Clin Rheumatol. 2016;35:1377-82.
     PubMed     Text format     Abstract available
     
     
     April 2016
223. TADA M, Inui K, Sugioka Y, Mamoto K, et al
     Delayed wound healing and postoperative surgical site infections in patients with rheumatoid arthritis treated with or without biological disease-modifying antirheumatic drugs.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
224. YE H, Su Y, Li R, Zhao J, et al
     Comparison of three classification criteria of rheumatoid arthritis in an inception early arthritis cohort.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
225. MALAVIYA AN, Gogia SB
     Treatment of rheumatoid arthritis (RA) in India-how and by whom: results from a speciality clinic-use of low-dose methotrexate (MTX) was inexplicably suboptimal.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
226. LOBO FS, Dossi MO, Batista L, Shinzato MM, et al
     Hearing impairment in patients with rheumatoid arthritis: association with anti-citrullinated protein antibodies.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
227. ESER B, Sahin N
     Evaluation of tool-like receptor-2 and 4 and interleukin-6 gene expressions in Turkish rheumatoid arthritis patients.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
228. GALVAO TF, Zimmermann IR, da Mota LM, Silva MT, et al
     Withdrawal of biologic agents in rheumatoid arthritis: a systematic review and meta-analysis.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
229. HAN GM, Han XF
     Comorbid conditions are associated with healthcare utilization, medical charges and mortality of patients with rheumatoid arthritis.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
230. LI L, Wen W, Jia R, Li Y, et al
     GITRL is associated with increased autoantibody production in patients with rheumatoid arthritis.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
231. GUTIERREZ M, Pineda C, Salaffi F, Raffeiner B, et al
     Is ankle involvement underestimated in rheumatoid arthritis? Results of a multicenter ultrasound study.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
232. ACAR A, Guzel S, Sarifakioglu B, Guzel EC, et al
     Calprotectin levels in patients with rheumatoid arthritis to assess and association with exercise treatment.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
233. WANG F, Chen FF, Gao WB, Wang HY, et al
     Identification of citrullinated peptides in the synovial fluid of patients with rheumatoid arthritis using LC-MALDI-TOF/TOF.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
234. LANGE U, Dischereit G, Tarner I, Frommer K, et al
     The impact of serial radon and hyperthermia exposure in a therapeutic adit on pivotal cytokines of bone metabolism in rheumatoid arthritis and osteoarthritis.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
235. FATIMAH N, Salim B, Nasim A, Hussain K, et al
     Frequency of methotrexate intolerance in rheumatoid arthritis patients using methotrexate intolerance severity score (MISS questionnaire).
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
236. SFRISO P, Caso F, Filardo GS, Botsios C, et al
     Impact of 24 months of anti-TNF therapy versus methotrexate on body weight in patients with rheumatoid arthritis: a prospective observational study.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
237. QUINTANA-DUQUE MA, Rondon-Herrera F, Mantilla RD, Calvo-Paramo E, et al
     Predictors of remission, erosive disease and radiographic progression in a Colombian cohort of early onset rheumatoid arthritis: a 3-year follow-up study.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
238. DIMITRIADES VR, Sorensen R
     Rheumatologic manifestations of primary immunodeficiency diseases.
     Clin Rheumatol. 2016;35:843-50.
     PubMed     Text format     Abstract available
     
     
     
239. HERNANDEZ-DIAZ C, Ventura-Rios L, Gutierrez M, Roth J, et al
     Ultrasonography in pediatric rheumatology in Latin America. Expanding the frontiers.
     Clin Rheumatol. 2016;35:1077-80.
     PubMed     Text format     Abstract available
     
     
     
240. YANG Y, Peng L, Ma W, Yi F, et al
     Autoantigen-targeting microRNAs in Sjogren's syndrome.
     Clin Rheumatol. 2016;35:911-7.
     PubMed     Text format     Abstract available
     
     
     
241. MURALIDHARAN N, Mariaselvam CM, Mithun CB, Negi VS, et al
     Reduced folate carrier-1 80G > A gene polymorphism is not associated with methotrexate treatment response in South Indian Tamils with rheumatoid arthritis.
     Clin Rheumatol. 2016;35:879-85.
     PubMed     Text format     Abstract available
     
     
     
242. MARIBO T, de Thurah A, Stengaard-Pedersen K
     Patient-self assessment of flare in rheumatoid arthritis: translation and reliability of the Flare instrument.
     Clin Rheumatol. 2016;35:1053-8.
     PubMed     Text format     Abstract available
     
     
     
243. LEUNG YY, Kwan J, Chan P, Poon PK, et al
     A pilot evaluation of Arthritis Self-Management Program by lay leaders in patients with chronic inflammatory arthritis in Hong Kong.
     Clin Rheumatol. 2016;35:935-41.
     PubMed     Text format     Abstract available
     
     
     March 2016
244. ZAMORA-LEGOFF JA, Achenbach SJ, Crowson CS, Krause ML, et al
     Opioid use in patients with rheumatoid arthritis 2005-2014: a population-based comparative study.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
245. AKIYAMA M, Kaneko Y, Kondo H, Takeuchi T, et al
     Comparison of the clinical effectiveness of tumour necrosis factor inhibitors and abatacept after insufficient response to tocilizumab in patients with rheumatoid arthritis.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
246. RINCON JF, Cano DL, Morales SJ, Jimenez ML, et al
     The functional PTPN22 C1858T polymorphism confers risk for rheumatoid arthritis in patients from Central Mexico.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
247. KIM SK, Choe JY, Park SH, Lee H, et al
     No predictive effect of body mass index on clinical response in patients with rheumatoid arthritis after 24 weeks of biological disease-modifying antirheumatic drugs: a single-center study.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
248. CARDONA-OSPINA JA, Vera-Polania F, Rodriguez-Morales AJ
     Chikungunya or not, differential diagnosis and the importance of laboratory confirmation for clinical and epidemiological research: comment on the article by Rosario et al.
     Clin Rheumatol. 2016;35:829-30.
     PubMed     Text format    
     
     
     
249. JAYAKANTHAN K, Ramya J, Mandal SK, Sandhya P, et al
     Younger patients with primary Sjogren's syndrome are more likely to have salivary IgG anti-muscarinic acetylcholine receptor type 3 antibodies.
     Clin Rheumatol. 2016;35:657-62.
     PubMed     Text format     Abstract available
     
     
     
250. TER BORG EJ, Kelder JC
     Polyarthritis in primary Sjogren's syndrome represents a distinct subset with less pronounced B cell proliferation a Dutch cohort with long-term follow-up.
     Clin Rheumatol. 2016;35:649-55.
     PubMed     Text format     Abstract available
     
     
     
251. AUGUSTO KL, Bonfa E, Pereira RM, Bueno C, et al
     Metabolic syndrome in Sjogren's syndrome patients: a relevant concern for clinical monitoring.
     Clin Rheumatol. 2016;35:639-47.
     PubMed     Text format     Abstract available
     
     
     
252. RUBAN TN, Jacob B, Pope JE, Keystone EC, et al
     The influence of age at disease onset on disease activity and disability: results from the Ontario Best Practices Research Initiative.
     Clin Rheumatol. 2016;35:759-63.
     PubMed     Text format     Abstract available
     
     
     
253. JAUREGUI JJ, Kapadia BH, Dixit A, Naziri Q, et al
     Thirty-day complications in rheumatoid patients following total knee arthroplasty.
     Clin Rheumatol. 2016;35:595-600.
     PubMed     Text format     Abstract available
     
     
     
254. GONZALEZ GARCIA A, Callejas Rubio JL, Rios Fernandez R, Ortego Centeno N, et al
     Pulmonary Langerhans Histiocytosis: an uncommon cause of interstitial pneumonia in a patient with Sjogren syndrome.
     Clin Rheumatol. 2016;35:825-8.
     PubMed     Text format     Abstract available
     
     
     
255. BISHARA R, Braun-Moscovici Y, Dagan A, Toledano K, et al
     Severe hyperferritinemia--a clue for severe hepatitis in a patient with adult-onset Still's disease.
     Clin Rheumatol. 2016;35:795-800.
     PubMed     Text format     Abstract available
     
     
     
256. FINA-AVILES F, Medina-Peralta M, Mendez-Boo L, Hermosilla E, et al
     The descriptive epidemiology of rheumatoid arthritis in Catalonia: a retrospective study using routinely collected data.
     Clin Rheumatol. 2016;35:751-7.
     PubMed     Text format     Abstract available
     
     
     February 2016
257. KRAUSE D, Gabriel B, Herborn G, Braun J, et al
     Response to methotrexate predicts long-term patient-related outcomes in rheumatoid arthritis.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
258. FISHMAN P, Cohen S
     The A adenosine receptor (AAR): therapeutic target and predictive biological marker in rheumatoid arthritis.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
259. AKAI T, Taniguchi D, Oda R, Asada M, et al
     Prediction of radiographic progression in synovitis-positive joints on maximum intensity projection of magnetic resonance imaging in rheumatoid arthritis.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
260. STEUNEBRINK LM, Vonkeman HE, Ten Klooster PM, Hoekstra M, et al
     Recently diagnosed rheumatoid arthritis patients benefit from a treat-to-target strategy: results from the DREAM registry.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
261. KOJIMA T, Takahashi N, Funahashi K, Asai S, et al
     Improved safety of biologic therapy for rheumatoid arthritis over the 8-year period since implementation in Japan: long-term results from a multicenter observational cohort study.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
262. VEGA-MORALES D, Loredo-Alanis SA, Garza-Elizondo MA
     Pain-related comorbidities and medication absence as predictors of clinical remission in RA.
     Clin Rheumatol. 2016;35:553-4.
     PubMed     Text format    
     
     
     
263. PIERINGER H, Puchner R, Pohanka E, Danninger K, et al
     Power of national economy, disease control and employment status in patients with RA-an analytical multi-site ecological study.
     Clin Rheumatol. 2016;35:461-5.
     PubMed     Text format     Abstract available
     
     
     
264. SASAKI T, Nakamura W, Inokuma S, Matsubara E, et al
     Characteristic features of tacrolimus-induced lung disease in rheumatoid arthritis patients.
     Clin Rheumatol. 2016;35:541-5.
     PubMed     Text format     Abstract available
     
     
     
265. DE THURAH A, Maribo T, Stengaard-Pedersen K
     Patient self-assessment of flare in rheumatoid arthritis: criterion and concurrent validity of the Flare instrument.
     Clin Rheumatol. 2016;35:467-71.
     PubMed     Text format     Abstract available
     
     
     
266. MACMULLAN PA, Madigan AM, Paul N, Peace AJ, et al
     Sulfasalazine and its metabolites inhibit platelet function in patients with inflammatory arthritis.
     Clin Rheumatol. 2016;35:447-55.
     PubMed     Text format     Abstract available
     
     
     January 2016
267. PIANTONI S, Colombo E, Tincani A, Airo P, et al
     Predictive factors of abatacept therapy discontinuation in patients with rheumatoid arthritis.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
268. GARDETTE A, Ottaviani S, Sellam J, Berenbaum F, et al
     Body mass index and response to tocilizumab in rheumatoid arthritis: a real life study.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
269. LENG X, Xiao W, Xu Z, Zhu X, et al
     Ultrasound7 versus ultrasound12 in monitoring the response to infliximab in patients with rheumatoid arthritis.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
270. LI R, Liu X, Ye H, Yao HH, et al
     Magnetic resonance imaging in early rheumatoid arthritis: a multicenter, prospective study.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
271. DE CUYPER E, De Gucht V, Maes S, Van Camp Y, et al
     Determinants of methotrexate adherence in rheumatoid arthritis patients.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
272. VASILJEVIC D, Veselinovic M, Jovanovic M, Jeremic N, et al
     Evaluation of the effects of different supplementation on oxidative status in patients with rheumatoid arthritis.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
273. HAH JH, An SY, Sim S, Kim SY, et al
     A population-based study on the association between rheumatoid arthritis and voice problems.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
274. ILTER A, Kiris A, Karkucak M, Sahin M, et al
     Arterial stiffness is associated with left ventricular dysfunction in patients with rheumatoid arthritis.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
275. BEN KILANI MS, Achour Y, Perea J, Cornelis F, et al
     Characterization of copy number variants for CCL3L1 gene in rheumatoid arthritis for French trio families and Tunisian cases and controls.
     Clin Rheumatol. 2016.
     PubMed     Text format     Abstract available
     
     
     
276. KOJIMA T, Takahashi N, Kaneko A, Kida D, et al
     Predictive factors for achieving low disease activity at 52 weeks after switching from tumor necrosis factor inhibitors to abatacept: results from a multicenter observational cohort study of Japanese patients.
     Clin Rheumatol. 2016;35:219-25.
     PubMed     Text format     Abstract available
     
     
     
277. CHEN Y, Sun J, Yang Y, Huang Y, et al
     Malignancy risk of anti-tumor necrosis factor alpha blockers: an overview of systematic reviews and meta-analyses.
     Clin Rheumatol. 2016;35:1-18.
     PubMed     Text format     Abstract available
     
     
     
278. GUO Q, Zha X, Li C, Jia Y, et al
     Serum calprotectin--a promising diagnostic marker for adult-onset Still's disease.
     Clin Rheumatol. 2016;35:73-9.
     PubMed     Text format     Abstract available
     
     
     
279. OLIVARES-MARTINEZ E, Hernandez-Ramirez DF, Nunez-Alvarez CA, Cabral AR, et al
     The amount of citrullinated proteins in synovial tissue is related to serum anti-cyclic citrullinated peptide (anti-CCP) antibody levels.
     Clin Rheumatol. 2016;35:55-61.
     PubMed     Text format     Abstract available
     
     
     
280. BEN-ZVI I, Goldenberg I, Matetzky S, Grossman C, et al
     The impact of inflammatory rheumatic diseases on the presentation, severity, and outcome of acute coronary syndrome.
     Clin Rheumatol. 2016;35:233-7.
     PubMed     Text format     Abstract available
     
     
     
281. SINGH JA, Ramachandran R
     Time trends in total ankle arthroplasty in the USA: a study of the National Inpatient Sample.
     Clin Rheumatol. 2016;35:239-45.
     PubMed     Text format     Abstract available
     
     
     December 2015
282. COLMEGNA I, Hitchon CA, Bardales MC, Puri L, et al
     High rates of obesity and greater associated disability among people with rheumatoid arthritis in Canada.
     Clin Rheumatol. 2015.
     PubMed     Text format     Abstract available
     
     
     
283. BERGSTRA SA, Markusse IM, Akdemir G, Ronday HK, et al
     Erosions in the foot at baseline are predictive of orthopaedic shoe use after 10 years of treat to target therapy in patients with recent onset rheumatoid arthritis.
     Clin Rheumatol. 2015.
     PubMed     Text format     Abstract available
     
     
     
284. IGUCHI-HASHIMOTO M, Hashimoto M, Fujii T, Hamaguchi M, et al
     The association between serious infection and disease outcome in patients with rheumatoid arthritis.
     Clin Rheumatol. 2015.
     PubMed     Text format     Abstract available
     
     
     
285. EL-ZORKANY B, Mokbel A, Gamal SM, Mousa M, et al
     Comparison of comorbidities of the Egyptian rheumatoid arthritis patients to the global cohort of the COMORA study: a post-hoc analysis.
     Clin Rheumatol. 2015.
     PubMed     Text format     Abstract available
     
     
     
286. ACKERMAN IN, Ngian GS, Van Doornum S, Briggs AM, et al
     A systematic review of interventions to improve knowledge and self-management skills concerning contraception, pregnancy and breastfeeding in people with rheumatoid arthritis.
     Clin Rheumatol. 2015.
     PubMed     Text format     Abstract available
     
     
     November 2015
287. YILDIRIM A, Surucu G, Dogan S, Karabiber M, et al
     Relationship between disease activity and hearing impairment in patients with rheumatoid arthritis compared with controls.
     Clin Rheumatol. 2015.
     PubMed     Text format     Abstract available
     
     
     
288. WANG P, Guan SY, Xu SZ, Li HM, et al
     Increased carotid intima-media thickness in rheumatoid arthritis: an update meta-analysis.
     Clin Rheumatol. 2015.
     PubMed     Text format     Abstract available
     
     
     
289. MORPETH T, Brenton-Rule A, Carroll M, Frecklington M, et al
     Fear of falling and foot pain, impairment and disability in rheumatoid arthritis: a case-control study.
     Clin Rheumatol. 2015.
     PubMed     Text format     Abstract available
     
     
     
290. IANNONE F, Lopalco G, Cantarini L, Galeazzi M, et al
     Efficacy and safety of combination therapy for preventing bone damage in rheumatoid arthritis.
     Clin Rheumatol. 2015.
     PubMed     Text format     Abstract available
     
     
     September 2015
291. LIU SS, Ding Y, Lou JQ
     IL-17, a potential therapeutic target for Sjogren's syndrome?
     Clin Rheumatol. 2015;34:1657-8.
     PubMed     Text format    
     
     
     May 2015
292. LIU J, Zhao Z, Zou Y, Zhang M, et al
     The expression of death decoy receptor 3 was increased in the patients with primary Sjogren's syndrome.
     Clin Rheumatol. 2015;34:879-85.
     PubMed     Text format     Abstract available
     
     
     
293. CITERA G, Ficco HM, Alamino RS, Pra FD, et al
     Work disability is related to the presence of arthritis and not to a specific diagnosis. Results from a large early arthritis cohort in Argentina.
     Clin Rheumatol. 2015;34:929-33.
     PubMed     Text format     Abstract available
     
     
     
294. GRANADOS Y, Cedeno L, Rosillo C, Berbin S, et al
     Prevalence of musculoskeletal disorders and rheumatic diseases in an urban community in Monagas State, Venezuela: a COPCORD study.
     Clin Rheumatol. 2015;34:871-7.
     PubMed     Text format     Abstract available
     
     
     
295. KATADA H, Yukawa N, Urushihara H, Tanaka S, et al
     Prescription patterns and trends in anti-rheumatic drug use based on a large-scale claims database in Japan.
     Clin Rheumatol. 2015;34:949-56.
     PubMed     Text format     Abstract available
     
     
     April 2015
296. MOUYIS M, Fitz-Clarence H, Manson J, Ciurtin C, et al
     Teriparatide: an unexpected adjunct for the treatment of a long-standing infected elbow prosthesis prevented arm amputation.
     Clin Rheumatol. 2015;34:799-800.
     PubMed     Text format     Abstract available
     
     
     
297. WITTE T
     Methotrexate as combination partner of TNF inhibitors and tocilizumab. What is reasonable from an immunological viewpoint?
     Clin Rheumatol. 2015;34:629-34.
     PubMed     Text format     Abstract available
     
     
     
298. KREITENBERG AJ, Ortiz EC, Arkfeld DG
     Priapism after tumor necrosis factor alpha inhibitor use.
     Clin Rheumatol. 2015;34:801-2.
     PubMed     Text format     Abstract available
     
     
     March 2015
299. LIANG MH, Couto MC, Duarte CC, Gall V, et al
     An Internet-based technique for the identification of persons with symptoms of inflammatory polyarthritis of less than 12 weeks.
     Clin Rheumatol. 2015;34:465-70.
     PubMed     Text format     Abstract available
     
     
     
300. BAGNATO G, De Andres I, Sorbara S, Verduci E, et al
     Pain threshold and intensity in rheumatic patients: correlations with the Hamilton Depression Rating scale.
     Clin Rheumatol. 2015;34:555-61.
     PubMed     Text format     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: